Viewing Study NCT02159612


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-02-17 @ 4:15 PM
Study NCT ID: NCT02159612
Status: COMPLETED
Last Update Posted: 2015-05-14
First Post: 2014-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy
Sponsor: Grete Andersen, MD
Organization:

Study Overview

Official Title: Disease Progression in Facioscapulohumeral Muscular Dystrophy - 1 Year MRI Follow-up
Status: COMPLETED
Status Verified Date: 2015-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FSHD
Brief Summary: An investigation of disease progression in adult danish patients with facioscapulohumeral muscular dystrophy. The disease progression is followed for a year with two test-days, including functional muscle tests and a MRI scan of muscles in the back and legs.
Detailed Description: A cohort of adult danish patients with facioscapulohumeral muscular dystrophy is invited to perform a MRI scan to describe the relation between backpain and disease affection in back muscles. After one year they are re-invited to perform another MRI scan to follow the disease progression.

The MRI scan is done to measure the quantity and quality of the muscles in the back, thigh and calf. Further, investigators investigate the muscle function by measuring of muscle strength in legs and in the back together with three functional tests. A walking test (6MWT), a stair test (14SST), and a chair test (5-TSTST). Self-assessment of back pain is measured by a standardized questionnaire about backpain.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: